公众号 / 文章泌尿生殖技术与安全PET

前列腺癌PSMA PET/CT报告标准化与AI辅助解读

Standardizing PSMA PET/CT reporting in prostate cancer: from structured frameworks to AI-assisted interpretation.
PubMed 文献 · Abdom Radiol (NY) · 2026-06-19

本文针对前列腺癌PSMA PET/CT报告异质性问题,提出以临床问题驱动的解读工作流。作者建议用PROMISE V2进行分期、用PSMA-RADS术语描述模棱两可病灶,并整合入最小结构化报告模板。AI工具可在病灶检测、量化、纵向匹配和报告预填充方面提供医生监督下的决策支持。

要点

  • 印象部分用PROMISE V2分期,模棱两可病灶用PSMA-RADS术语描述
  • 采用分区搜索模式,重点注意腹盆腔常见假阳性与示踪剂相关问题
  • AI工具定位为医生监督下的决策支持,用于病灶检测、量化与纵向匹配

核心结论

  • 推荐PROMISE V2分期作为印象结构,PSMA-RADS描述模棱两可病灶,整合入最小结构化报告模板
  • AI工具可辅助病灶检测、量化、纵向匹配和结构化报告预填充,但需医生监督

研究设计与样本

  • 本文为针对PSMA PET/CT阅片者的实用性解读工作流建议文章

关键影像表现/征象

  • 腹盆腔存在常见假阳性表现,需注意示踪剂依赖性问题
  • 小淋巴结转移检出敏感度有限,摄取评估受部分容积效应影响

诊断标准与关键数值

  • PROMISE V2整合PRIMARY评分、分子影像TNM分期和PSMA表达评分
  • PSMA-RADS 2.0支持病灶水平表征
  • PSMA PET进展标准和RECIP 1.0用于治疗反应评估

临床应用与阅片要点

  • 采用临床问题驱动的方法选择解读框架
  • 采用分区搜索模式进行系统性阅片
  • 描述模棱两可病灶时使用PSMA-RADS术语
  • 注意综合框架与临床可行性的平衡

局限性

  • 小淋巴结转移的检出敏感度有限
  • 摄取评估受部分容积效应影响
  • 临床实际报告中框架采纳率有限、病灶记录不一致、偶发发现处理不一、纵向比较欠佳

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PSMA PET/CT is increasingly used for prostate cancer staging, restaging, treatment selection, and therapy response assessment. In parallel, several interpretation frameworks have been developed to standardize reporting. PROMISE version 2 integrates the PRIMARY score for local disease, molecular imaging TNM staging, and a PSMA expression score. PSMA-RADS 2.0 supports lesion-level characterization, whereas response systems such as the PSMA PET progression criteria and RECIP 1.0 focus on treatment response assessment. Despite the availability of these systems and professional society guidance, real-world reporting remains heterogeneous, with limited framework adoption, inconsistent lesion documentation, variable handling of incidental findings, and suboptimal longitudinal comparison, all of which may complicate multidisciplinary communication and clinical decision-making. Emerging automation and artificial intelligence (AI)-based tools may help address some of these gaps by supporting lesion detection, quantification, longitudinal matching, and prepopulation of structured report elements; however, their current role is best regarded as physician-supervised decision support rather than autonomous interpretation. This article provides a pragmatic interpretation workflow for PSMA PET/CT readers. We propose a clinical question-driven approach to framework selection, a compartment-based search pattern, and a minimal synoptic reporting template. Targeted pearls and pitfalls emphasize common abdominopelvic mimics and tracer-dependent issues. We also address frequent interpretive challenges, including limited sensitivity for microscopic nodal disease, partial-volume effects in uptake assessment, the trade-off between comprehensive frameworks and real-world feasibility, and the evolving role of AI-assisted structured reporting. Take-home message: A practical reporting approach is to standardize the impression with PROMISE V2 staging, describe equivocal lesions using PSMA-RADS terminology, and incorporate these elements into a minimal synoptic template. Physician-supervised automation and AI-assisted tools may further support lesion detection, quantification, longitudinal matching, and structured-report prepopulation within this workflow.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Arita, Zheng, Wen, et al. Standardizing PSMA PET/CT reporting in prostate cancer: from structured frameworks to AI-assisted interpretation. Abdom Radiol (NY). 2026. PMID: 42319425. doi:10.1007/s00261-026-05593-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。